The $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.
Read Press ReleaseAfter successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers.
Read Press ReleaseThe $50,000 Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.
Read Press ReleaseLegionnaires' disease cases have increased nearly tenfold in recent decades, leading to thousands of hospitalizations and deaths. Outbreaks are linked to Legionella, a bacteria found in potable water systems in large facilities like hospitals, multi-family buildings, resorts, and office buildings. A recently published study shows that copper-silver ionization effectively controls Legionella in building water systems to prevent Legionnaires' disease.
Read Press ReleaseAll-new Yunuverse cloud community capabilities, now standard on the Yunu platform, make it possible for over 1,000 on-demand specialty-trained radiologists, technologists, and study staff to be invited and instantly participate in any of the 4,000 in-flight imaging clinical trials running on the system today. Cancer centers may now extend the reach of trial programs to satellite sites and imaging centers, improving patient access to sophisticated oncology trials.
Read Press ReleaseAmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.
Read Press ReleaseThe long-duration soft-tissue repair ultrasound device provides healthcare professionals with another proven method of accelerating and enhancing healing.
Read Press ReleaseTHE COVID-19 DETECTION FOUNDATION (dba VIRUFY) COVID-19 SCREENING THROUGH ARTIFICIAL INTELLIGENCE / MACHINE LEARNING TECHNOLOGY IS THE NEWEST MEMBER OF BARDA'S DIVISION OF RESEARCH, INNOVATION, AND VENTURES (DRIVe) MEDICAL COUNTERMEASURES PORTFOLIO
Read Press ReleasePureWay Compliance, Inc. provides safe sharps (needles, syringes, etc.) disposal to patients that self inject at home and do not wish to discard their needles in the trash. With increasing awareness of the hazards of dirty needles, patients are looking for safe and eco-friendly options to safely dispose of sharps at home. PureWay since 2013 has provided over 300,000 patients with sharps disposal by mail systems through strategic agreements with pharmaceutical manufacturers, non-profits like SafeNeedleDisposal and through stewardship programs.
Read Press ReleaseThe device's ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.
Read Press Release•• Complete epithelial recovery was achieved by 67% of subjects receiving NEXAGON, as opposed to 27% receiving Vehicle alone
•• NEXAGON was well-tolerated demonstrating a safety profile similar to vehicle
•• Amber plans to initiate the NEXPEDE-1 Phase 2/3 clinical trial in subjects with PCED of various etiologies in Q1 2023 ••
The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).
Read Press ReleaseGb Sciences' innovative approach harnesses the power of plant-based treatments as simplified mixtures that target dangerous hyperinflammatory responses to viral infections.
Read Press ReleaseThe Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.
Read Press ReleaseExpert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness.
Read Press ReleaseAs published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.
Read Press ReleaseAt the Annual Summit, Dr. Andrea Small-Howard is presenting a Keynote Address that includes data from case studies demonstrating the utility of Gb Sciences' proprietary PhAROS drug discovery platform.
Read Press ReleaseClinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators
Read Press ReleaseVirtual workshop on Nov. 17-18 bridges the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.
Read Press ReleaseGb Sciences' anxiety formulations were previously identified using the company's AI-driven PhAROS™ platform, and they have now been evaluated using preclinical zebrafish models of stress at the National Research Council of Canada.
Read Press ReleaseFirst joint research project between Sanofi and the BioMed X Institute, co-creation of a next-generation virtual patient engine for clinical translation of drug candidates
Read Press ReleaseThe Optejet® ophthalmic drug device is designed to precisely administer medication to the eye, potentially treating patients' conditions through gentler, more efficient dosing.
Read Press Release